AstraZeneca (AZN) CEO Brennan to Retire

April 26, 2012 6:30 AM EDT Send to a Friend
AstraZeneca (NYSE: AZN) announced that Chief Executive Officer and Board member, David Brennan has decided to retire.

Following David’s decision, the Board has asked Executive Director and Chief Financial Officer Simon Lowth to act as interim Chief Executive Officer from 1 June 2012 until a permanent successor is in place. Julie Brown, Vice President Group Finance, will become interim Chief Financial Officer on the same date. David Brennan will retire from AstraZeneca and relinquish his Board responsibilities on 1 June 2012.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Management Changes

Add Your Comment